|
|
Bayer AG ADR
OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 07/02/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization52,265 mln
Float3,930 mln
Earnings Date08/04/2026
1-Year Forecast
14.19
Limited downside
Key Fundamentals
EPS-0.62
ROE-7.61
RPS13.39
ROIC7.80
ROA-2.11
Interest Cover3.58
EBITDA, mln3,377
EV / EBITDA25.42
EV / EBIT925
Revenue, mln52,615
EV / Revenue1.66
Financial Strength
Altman Z-Score0.79
Piotroski F-Score
7
/ 9
Beneish M-Score-2.78
Price to Intrinsic Value0.91
1-Year Target Price14.19
Shiller PE Ratio52.31
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
15.39% |
92
/ 100
 |
| 1 Month |
53.85% |
97
/ 100
 |
| 2 Months |
38.71% |
89
/ 100
 |
| 6 Months |
40.89% |
84
/ 100
 |
| 1 Year |
95% |
86
/ 100
|
|
| |
